Philippe C. Bishop

Philippe C. Bishop

Chief Tech/Sci/R&D Officer at ATRECA, INC.

59 year
Health Technology
Consumer Services

Profile

Philippe C.
Bishop
was the founder of Aratinga Bio, Inc. (founded in 2017) where he held the title of Chief Medical Officer & Executive Vice President.
Currently, he is the Chief Medical Officer at Atreca, Inc. (since 2023).
Previously, he worked as a Senior Director at Johnson & Johnson Pharmaceutical Services LLC, Global Clinical Director at Sanofi-Aventis, Inc. (2003-2005), Vice President-Product Development at Genentech, Inc. (2014), Senior VP-Hematology & Oncology Therapeutics at Gilead Sciences, Inc. (2014-2016), and Chief Medical Officer-Oncology at Clover Biopharmaceuticals Ltd.
He received his undergraduate degree from Loyola Marymount University in 1985 and his doctorate degree from the School of Medicine University of Nevada in 1993.

Philippe C. Bishop active positions

CompaniesPositionStart
ATRECA, INC. Chief Tech/Sci/R&D Officer 08/01/2023
All active positions of Philippe C. Bishop

Former positions of Philippe C. Bishop

CompaniesPositionEnd
GILEAD SCIENCES, INC. Corporate Officer/Principal 31/01/2016
Corporate Officer/Principal 16/12/2014
Chief Tech/Sci/R&D Officer 31/12/2004
Director/Board Member -
Aratinga Bio, Inc. Founder -
See the detail of Philippe C. Bishop's experience

Training of Philippe C. Bishop

Loyola Marymount University Undergraduate Degree
School of Medicine University of Nevada Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philippe C. Bishop's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
GILEAD SCIENCES, INC.

Health Technology

ATRECA, INC.

Health Technology

CLOVER BIOPHARMACEUTICALS, LTD.

Health Technology

Private companies4

Health Technology

Health Technology

Aratinga Bio, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Philippe C. Bishop